Correlation Between Anheuser Busch and Tarsus Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Anheuser Busch and Tarsus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Anheuser Busch and Tarsus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Anheuser Busch Inbev and Tarsus Pharmaceuticals, you can compare the effects of market volatilities on Anheuser Busch and Tarsus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Anheuser Busch with a short position of Tarsus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Anheuser Busch and Tarsus Pharmaceuticals.

Diversification Opportunities for Anheuser Busch and Tarsus Pharmaceuticals

-0.78

Correlation Coefficient

Anheuser Busch  Tarsus Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Anheuser and Tarsus is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Anheuser Busch Inbev and Tarsus Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tarsus Pharmaceuticals and Anheuser Busch is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Anheuser Busch Inbev are associated (or correlated) with Tarsus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tarsus Pharmaceuticals has no effect on the direction of Anheuser Busch i.e., Anheuser Busch and Tarsus Pharmaceuticals go up and down completely randomly.

Pair Corralation between Anheuser Busch and Tarsus Pharmaceuticals

Considering the 90-day investment horizon Anheuser Busch Inbev is expected to under-perform the Tarsus Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Anheuser Busch Inbev is 2.72 times less risky than Tarsus Pharmaceuticals. The stock trades about -0.15 of its potential returns per unit of risk. The Tarsus Pharmaceuticals is currently generating about 0.31 of returns per unit of risk over similar time horizon. If you would invest  2,617  in Tarsus Pharmaceuticals on September 3, 2024 and sell it today you would earn a total of  2,425  from holding Tarsus Pharmaceuticals or generate 92.66% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Anheuser Busch Inbev  vs.  Tarsus Pharmaceuticals

Anheuser Busch Inbev

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Anheuser Busch Inbev has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Tarsus Pharmaceuticals

Risk-Adjusted Performance

24 of 100

Strong

Compared to the overall equity markets, risk-adjusted returns on investments in Tarsus Pharmaceuticals are ranked lower than 24 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively unsteady basic indicators, Tarsus Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Anheuser Busch and Tarsus Pharmaceuticals

The main advantage of trading using opposite Anheuser Busch and Tarsus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Anheuser Busch position performs unexpectedly, Tarsus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tarsus Pharmaceuticals will offset losses from the drop in Tarsus Pharmaceuticals' long position.

The idea behind Anheuser Busch Inbev and Tarsus Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.